| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 17 |
| 1 | ASPIRIN | 17 |
| 2 | ASPIRIN 325 MG | 16 |
| 3 | ASPIRIN 81 MG | 16 |
| 4 | LEUPROLIDE ACETATE | 13 |
| 5 | FINASTERIDE | 11 |
| 6 | OMEPRAZOLE MAGNESIUM | 9 |
| 7 | PREDNISOLONE | 9 |
| 8 | PREDNISOLONE ORAL | 9 |
| 9 | PREDNISOLONE ORAL SOLUTION | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIOGLITAZONE AND GLIMEPIRIDE | 1 | 0.0108 |
| 1 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 2 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 3 | SILVER SULFADIAZINE | 2 | 0.0009 |
| 4 | OMEPRAZOLE AND SODIUM BICARBONATE | 2 | 0.0007 |
| 5 | IDARUCIZUMAB | 1 | 0.0007 |
| 6 | SAXAGLIPTIN | 1 | 0.0007 |
| 7 | HYALURONATE SODIUM | 1 | 0.0007 |
| 8 | ALFUZOSIN HCL | 2 | 0.0006 |
| 9 | PRALSETINIB | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 1 | Corticosteroid [EPC] | 20 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 11 |
| 4 | Benzodiazepine [EPC] | 11 |
| 5 | Kinase Inhibitor [EPC] | 11 |
| 6 | Thalidomide Analog [EPC] | 8 |
| 7 | Thiazide Diuretic [EPC] | 8 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 8 |
| 9 | beta-Adrenergic Blocker [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 4 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 7 | Androgen Receptor Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 2 | 0.0001 |
| 9 | Alkaloid [EPC] | 2 | 0.0001 |